DILLON KAYSER: Open Payments
NPI 1881199784 · CHARLOTTESVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$188 in 9 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $188
Food & beverage: $188
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 3 | $73 |
| Otsuka America Pharmaceutical, Inc. | 3 | $55 |
| Lundbeck LLC | 1 | $22 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
| ABBVIE INC. | 1 | $17 |
Products named: Qelbree, REXULTI, SPRAVATO, ABILIFY ASIMTUFII, VRAYLAR.
Industry payments across VA — which companies pay providers there.
